Tectonic Therapeutic | AVRO - Beneficio Operativo

Precio De Mercado
31.48
Cambio Diario
-0.92 -2.84%
Mensual
49.05%
Anual
43.61%
Q1 Expectativa
32.30




Beneficio Operativo Cambio Fecha
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Knight Therapeutics CAD 2.94M 2.4M 2025-09
Laboratorios Farma EUR 135.05M 49.84M 2023-12
MacroGenics USD 18.64M 55.4M 2025-09
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organigram Holdings CAD -28.05M 7.76M 2025-09
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pfizer USD 4.65B 3.99B 2025-12
Pharma Mar EUR 43.61M 47.57M 2025-12
Qiagen NV USD 121.88M 15.41M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Takeda JPY 168.82B 479.89B 2025-12
Tilray USD -20.01M 9.34M 2025-09
Zz Pientze Pharmaceu CNY 501.33M 52.54M 2025-09